We are live on ! Find out more
HW

Hamilton Wealth Portfolio holdings

AUM $546M
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+31.66%
3 Year Est. Return
+107.51%
5 Year Est. Return
+133.6%
10 Year Est. Return
AUM
$479M
AUM Growth
+$32.2M
Cap. Flow
-$906K
Cap. Flow %
-0.19%
Top 10 Hldgs %
52.74%
Holding
135
New
31
Increased
45
Reduced
27
Closed
20

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.27%
2 Technology 23.95%
3 Communication Services 11.87%
4 Healthcare 7.75%
5 Consumer Discretionary 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
126
Coca-Cola
KO
$379B
-2,970
Closed -$210K
LSF icon
127
Laird Superfood
LSF
$42.4M
-10,000
Closed -$63K
NVO
128
Novo Nordisk
NVO
$191B
-52,998
Closed -$3.66M
PPH icon
129
VanEck Pharmaceutical ETF
PPH
$1.01B
-132,463
Closed -$11.7M
TSLZ icon
130
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$29.2M
-2,640
Closed -$87.1K
TZA icon
131
Direxion Daily Small Cap Bear 3x ETF
TZA
$260M
-4,164
Closed -$494K
UNH icon
132
UnitedHealth
UNH
$337B
-1,129
Closed -$352K
VERV
133
DELISTED
Verve Therapeutics
VERV
-10,000
Closed -$112K
VTEB icon
134
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.4B
-9,255
Closed -$454K
VWOB icon
135
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.3B
-3,775
Closed -$247K

Similar funds

Hamilton Wealth's Q3 2025 Portfolio in Review

As of Q3 2025, Hamilton Wealth held 135 positions worth $479M, up 7.2% from $447M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Hamilton Wealth's Q3 2025 filing shows 31 new, 45 increased, 27 reduced and 20 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 12,581 shares worth $7.07M. The largest sale was VanEck Pharmaceutical ETF, an estimated $11.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 53% a quarter earlier, followed by Technology and Communication Services.

  • Hamilton Wealth's largest Q3 2025 buy was Regeneron Pharmaceuticals: 12,581 shares worth $7.07M.
  • Hamilton Wealth added most to Direxion Daily Technology Bear 3x ETF in Q3 2025, an estimated $11.2M increase.
  • Hamilton Wealth's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $6.76M.
  • Hamilton Wealth fully exited VanEck Pharmaceutical ETF in Q3 2025, selling an estimated $11.7M.
  • Hamilton Wealth's ten largest holdings make up 53% of its $479M portfolio in Q3 2025.
  • Hamilton Wealth opened 31 new positions and closed 20 in Q3 2025.
  • Hamilton Wealth's portfolio value rose 7.2% quarter-over-quarter to $479M.

Based on Hamilton Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.